The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

• Principais autores: Antza C (Autor), Nirantharakumar K (Autor), Doundoulakis I (Autor), Tahrani AA (Autor), Toulis KA (Autor)
• Formato: Livro
• Publicado em: Dove Medical Press, 2019-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Christina Antza,1,* Krishnarajah Nirantharakumar,2,* Ioannis Doundoulakis,3 Abd A Tahrani,4–6 Konstantinos A Toulis2,313rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece; 2Institute of Applied Health Research, University of Birmingham, Bi...